Skip to main content

01.10.2011 | Original Article | Ausgabe 5/2011

Journal of Inherited Metabolic Disease 5/2011

Genistein supplementation in patients affected by Sanfilippo disease

Journal of Inherited Metabolic Disease > Ausgabe 5/2011
Verónica Delgadillo, Maria del Mar O’Callaghan, Rafael Artuch, Raquel Montero, Mercedes Pineda
Wichtige Hinweise
Communicated by: Ed Wraith
Competing interests: None declared



Mucopolysaccharidosis type III (Sanfilippo syndrome) is a group of autosomal recessive disorders caused by a deficiency in one of the four enzymes involved in the lysosomal degradation of heparan sulfate. Genistein supplementation has been proposed as a potential therapy for the reduction of substrates in patients with these disorders.


The aim of this study was to assess the effectiveness and potential side effects of genistein supplementation in MPS III patients.


Open-label study, with 19 children (10 males and 9 females) enrolled with confirmed diagnosis of MPS III (age range 2.8–19 years). Patients were supplemented with genistein (5 mg kg−1 day−1) for 1 year. Clinical evaluation, hair morphology, urinary glycosaminoglycan analysis, study of nutritional parameters, and other routine biochemical tests were performed.


We did not observe an improvement in the disability scale; after genistein treatment, in most patients there was an increased disability score or it remained unchanged. There was a relative decrease in the recurrence of infections and gastrointestinal symptoms, as well as improvement in skin texture and hair morphology. Glycosaminoglycan levels were above normal at all control points and showed great variability in their elimination.


Our results suggest that genistein supplementation at 5 mg kg−1 day−1 did not improve disability estimated by using a particular scale.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf

Alle e.Med Abos bis 30. April 2021 zum halben Preis!

Jetzt e.Med zum Sonderpreis bestellen!

Über diesen Artikel

Weitere Artikel der Ausgabe 5/2011

Journal of Inherited Metabolic Disease 5/2011 Zur Ausgabe

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin